Furthermore, a negative trend in the long-term 180-day mortality rate was noted, and the trial was then stopped midway per the recommendation from the DSMB.
← all excerpts
Effect of Neutrophil Elastase Inhibitor (Sivelestat Sodium) on Oxygenation in Patients with Sepsis-Induced Acute Respiratory Distress Syndrome.
1
—
—